The present study also suggested that knockdown of Smad4 to inhibit the TGFβ signal during chemotherapy may sensitize cancer cells to chemotherapy, in part through the inhibition of MDR p-gp expression and reversal of the EMT process. Here, SMAD4 is linked to cancer.